Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Behandlingsniveau og behandlingsstop ved benign lungesygdom

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Balanced translocation in a patient with abortus habitualis and normal karyotype

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The effect of antidepressants on brain volume

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Nyt studie viser, at motion beskytter mod depression

    Publikation: Bidrag til tidsskriftBidrag til avis - Kommentar/debatFormidling

  5. Gentagne diploid biparental molae

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.

Bidragets oversatte titelTreatment limitations or discontinuation in patients with benign pulmonary diseases
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind180
Udgave nummer39
ISSN0041-5782
StatusUdgivet - 24 sep. 2018

ID: 56582120